Ion News and Research

RSS

New hydrogel actuator has potential to interact safely with living tissues

Protein from a small, tasty mollusk inspired Michigan Technological University's Bruce P. Lee to invent a new type of hydrogel actuator.

6 Mar 2014

Researchers unlock controversial structure in heart cells

Brandeis University researchers have unlocked a controversial structure in heart cells responsible for regulating heart contractions.

5 Mar 2014

Biostatistics provides clues to understanding autism: an interview with Dr Knut M. Wittkowski, The Rockefeller University

The incidence of autism spectrum disorders has increased sharply since it was first described 60 years ago. Today, ASD affects more than 1% of all children in the U.S. and about half of them develop a life-long disability.

3 Mar 2014

Photoreactive compounds open new routes to treatment of neurological diseases

Photoreactive compounds developed by scientists of Ludwig-Maximilians-Universitaet (LMU) in Munich directly modulate nerve-cell function, and open new routes to the treatment of neurological diseases, including chronic pain and certain types of visual impairment.

3 Mar 2014

Researchers create new probe that freezes cells to "see" at greater detail without damaging

It's an odd twist. For scientists to determine if a cell is functioning properly, they must destroy it. This is what happens in X-ray fluorescence microscopy when biological specimens are exposed to ionizing radiation, which provides images with a level of detail that conventional microscopes just can't match.

26 Feb 2014

GOP readies new votes on health law mandate repeal, Medicare advantage cuts

In the meantime, one Democratic senator is pulling back from comments he made on repealing the health law.

25 Feb 2014

First Edition: February 24, 2014

Today's headlines include continuing coverage of Medicare Advantage payment rates, as well as a range of stories about the health law's Medicaid expansion and online insurance marketplaces.

24 Feb 2014

Biochrom launches EZ Nin Reagent for use in ion exchange chromatography systems

Biochrom Ltd, a manufacturer of quality scientific instruments for applications in the life science, clinical, and analytical markets, announced today the commercial launch of its EZ Nin ReagentTM, a ready-to-use ninhydrin formulation for use in ion exchange chromatography systems with post-column derivatisation for improved amino acid analysis.

From Biochrom Ltd. 24 Feb 2014

For Virginia's Medicaid expansion plan, the House votes no but the Senate votes yes

The votes will likely set up a conference committee showdown related to the state's two-year budget plan. Meanwhile, news outlets also report on developments from Arkansas, Mississippi and California.

24 Feb 2014

First Edition: February 21, 2014

Today's headlines include reports checking the status of different state health exchanges as well as efforts to expand Medicaid.

21 Feb 2014

New DNA Quantification kits may help scientists to quickly assess highly compromised human DNA

Forensic scientists can now more quickly assess the quantity and quality of human DNA in highly compromised and degraded casework samples and provide the critical information needed to drive informed decisions on subsequent steps in the analysis process, thanks to two new Life Technologies quantification solutions announced today by Thermo Fisher Scientific.

21 Feb 2014

The Future of DNA Sequencing

In this interview, Barret Bready discusses the current gold standards in DNA sequencing and how the Nabsys platform is revolutionizing this process.

18 Feb 2014

Study shows how Bcl-2 cancer-related protein signals cancer cells to live longer

A team of researchers from Case Western Reserve School of Medicine has discovered how the cancer-related protein Bcl-2 signals cancer cells to live longer.

14 Feb 2014

Scientists identify network of genes that controls human brain activity, memory and schizophrenia

Many psychiatric disorders are accompanied by memory deficits. Basel scientists have now identified a network of genes that controls fundamental properties of neurons and is important for human brain activity, memory and the development of schizophrenia.

14 Feb 2014

Calcivis Caries Activity Imaging System receives CE Mark in Europe

Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that its Calcivis Caries Activity Imaging System has been granted a CE Mark in Europe. A CE Mark is required before a medical device can be marketed in the EU and a number of other countries and signifies that the manufacturer meets the requirements of European legislation.

12 Feb 2014

Gilead submits NDA to FDA for fixed-dose combination of ledipasvir and sofosbuvir for hepatitis C infection

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg for the treatment of chronic hepatitis C genotype 1 infection in adults.

11 Feb 2014

Researchers shed new light on pain associated with bacterial infections

Components in the outer wall of bacteria directly activate pain sensors, triggering immediate pain and inflammatory responses. This finding by a multinational team of researchers led by Professor Karel Talavera (KU Leuven, Belgium) and Professor Félix Viana (Institute of Neuroscience, Spain) sheds new light on pain associated with bacterial infections and reveals a new target for drugs designed to treat them.

11 Feb 2014

Optogenetics technique allows scientists to control neurons' electrical activity

Optogenetics is a technique that allows scientists to control neurons' electrical activity with light by engineering them to express light-sensitive proteins. Within the past decade, it has become a very powerful tool for discovering the functions of different types of cells in the brain.

10 Feb 2014

Researchers develop multifunctional nanoparticle to pinpoint blood vessel plaques

A team of researchers, led by scientists at Case Western Reserve University, has developed a multifunctional nanoparticle that enables magnetic resonance imaging (MRI) to pinpoint blood vessel plaques caused by atherosclerosis.

7 Feb 2014

Rare and de novo mutations flesh out schizophrenia picture

Two studies in Nature show that rare disruptive and de novo mutations may contribute to the pathophysiology of schizophrenia.

6 Feb 2014